InvestorsHub Logo
Followers 6
Posts 364
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Monday, 08/19/2024 1:51:15 PM

Monday, August 19, 2024 1:51:15 PM

Post# of 410544
Regarding Fiscal Year 2025 and revenue. If we just maintain first quarter results of $18.8 million for each quarter it puts us at $75.2 million for 2025. Now, add in continued growth of Generic Adderall IR; continued growth of Generic Adderall XR with marketing Partner Prasco; launch and sales for generic APAP with Codeine, Generic Methotrexate, Generic Norco, Generic Percocet, & generic Dolophine, and approval/launch/sales for Generic Vyvanse. I think we will be well over $75.2 million!!!
The Future's So Bright, I Gotta Wear Shades!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News